Medicines have benefits and some have risks. Always read the label and use only as directed. If symptoms persist or you have side effects see your health professional. Brands and generics both contain the same active ingredient(s) and are medically equivalent. Some brands are marketed under different names by the same manufacturer depending on the country of origin. Images are provided as a reference only, the received medicine may vary in packaging, color, pill shape, etc, from one batch to the next. For an item marked "generic" any quality brand may be sent, however you will always receive the active ingredients ordered in the strength(s) ordered.
Tofranil (imipramine) is a tricyclic antidepressant primarily used to treat depression and, in patients at least 6 years of age, bedwetting, which is formally called nocturnal enuresis. Though not particularly common, it is also sometimes used in an assortment of other conditions, including chronic pain, night terrors, panic attacks, and migraines. The exact mechanism by which it works is unclear in all conditions.
The medication is administered by tablets, which may be taken once per day to several times per day, depending on the condition being treated and patient response. Treatment typically lasts at least a few months, sometimes much longer.
This product is also known by the brand name Antidep.
Treating Depression with Tofranil
Like most antidepressants, Tofranil is thought to work by stabilizing substances in the brain, such as serotonin, norepinephrine, dopamine and so forth. It may take about two to four weeks for substantial benefit to be seen, and dosage may be increased at that point if no there are no significant improvements.
Patients taking Tofranil report:
Some patients struggle with the first few months of treatment, especially if it is the first time taking an antidepressant; depression and other symptoms may briefly worsen. This is why antidepressants come with a warning about possibly increasing risk of suicide. Worsening symptoms are more likely to happen with patients who are under age 25, and most likely to happen during the first month of treatment. Younger patients or those with a history of suicide attempts or self-harm should be monitored closely for the first few weeks of treatment with Tofranil or any antidepressant.
Dosage should always be determined by a doctor, particularly in patients under 25. Standard treatment for adults is:
Treatment typically lasts 6 to 9 months, though this can vary.
Tofranil for Bedwetting
Tofranil can be used in patients age 6 and up for bedwetting when there is no known cause; other causes, such as physical complications or medication side effects should be ruled out first. Dosage should be determined by a doctor according the child's weight.
Treatment typically starts with low doses, increased in weekly increments if improvements are not seen. Tablets are typically administered about an hour prior to bed, though some have better results giving a half-dose in the afternoon and the other half before bed.
Duration of treatment should be established by a doctor.
Patients with preexisting medical conditions are at increased risk of experiencing serious side effects. Speak with a doctor about risks and warning signs before taking Tofranil if there is any history of:
At higher doses Tofranil is associated with a risk of heart problems. Warning signs include:
Tofranil can interact with a wide range of other medications, particularly other antidepressants. Always check with a doctor or pharmacist before mixing medications.